The Max Foundation and Tanner Pharma partner on innovative drug distribution model
The Max Foundation and Tanner Pharma Group have partnered to create an innovative distribution model to deliver oncology products to patients in need.
Pat Garcia-Gonzalez Wins UICC’s CEO Award
She won it! The Max Foundation is thrilled to announce that Pat Garcia-Gonzalez has won the Union for International Cancer Control’s CEO Award for 2018!
The Union for International Cancer Control (UICC) is a membership organization that aims to reduce the global cancer burden and promote greater equity in cancer care. Each year the UICC grants awards that aim to identify and celebrate best practices and inspirational figures among their members.
Pat received the CEO Award at this year’s World Cancer Congress in Kuala Lumpur, for her tremendous contributions to equity in cancer care and her visionary leadership as Chief Executive Officer of The Max Foundation. She was cheered on by friends, colleagues, and Max team members from around the globe.
Said Pat: “It is such an honor to receive this award, but it is not only for me. It’s really for the entire Max team and for all our many partners. My thanks go out to them for their daily efforts in making The Max Foundation possible and working tirelessly to create a world where all people can face cancer with dignity and hope.”
Pat had been one of three finalists for the award, alongside Asem Mansour of King Hussein Cancer Center in Jordan, and Wondu Bekele Woldemariam of Mathiwos Wondu-YeEthiopia Cancer Society. Our thanks and congratulations go out to all three finalists.
The Max Foundation would like to thank all our partners – physicians, pharmaceutical manufacturers, distribution and diagnostics companies, donors and supporters, and of course, patient associations – we could not do what we do with you.
Most of all, we’d like to thank the 18 different patient associations from across Asia that sent letters in support of Pat’s nomination. You are the inspiration for all we do and we are so very grateful for your support.
Visit the UICC website to learn more about the awards, the finalists, and our collective work to reduce the global cancer burden.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Related Articles
Closing cancer care gaps in LMICs requires patient-centered systems
On the sidelines of UNGA80, global health leaders explored ways to expand access to care and build resilient health systems, and the critical role partnerships play in ensuring sustainable impact. Read More
CMLPath to Care
In 2017 The Max Foundation, through its subsidiary MaxAid, and Novartis have renewed their commitment to patients by launching CMLPath to Care™ a new collaboration aimed at providing humanitarian access to treatment for CML and other rare cancers for those patients for whom no other form of local treatment access exists today. CMLPath to Care consists of humanitarian product donations and funding support from Novartis to Max, and an innovative new distribution model developed and implemented by Max and its international distributor, under the Max Access Solution umbrella.